Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2 -agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Singh, Dave, Prof, Papi, Alberto, Prof, Corradi, Massimo, Prof, Pavlišová, Ilona, MD, Montagna, Isabella, MSc, Francisco, Catherine, MSc, Cohuet, Géraldine, MSc, Vezzoli, Stefano, MSc, Scuri, Mario, MD, Vestbo, Jørgen, Prof
Published in The Lancet (British edition) (03.09.2016)
Published in The Lancet (British edition) (03.09.2016)
Get full text
Journal Article
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta 2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Singh, Dave, Papi, Alberto, Corradi, Massimo, Pavlisova, Ilona, Montagna, Isabella, Francisco, Catherine, Cohuet, Geraldine, Vezzoli, Stefano, Scuri, Mario, Vestbo, Joergen
Published in The Lancet (British edition) (01.09.2016)
Published in The Lancet (British edition) (01.09.2016)
Get full text
Journal Article
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting [beta]2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Singh, Dave, Papi, Alberto, Corradi, Massimo, Pavlisová, Ilona, Montagna, Isabella, Francisco, Catherine, Cohuet, Géraldine, Vezzoli, Stefano, Scuri, Mario, Vestbo, Jørgen
Published in The Lancet (British edition) (03.09.2016)
Published in The Lancet (British edition) (03.09.2016)
Get full text
Journal Article